Plasmodium falciparum histidine rich protein 2 (pfhrp2): an additional genetic marker suitable for anti-malarial drug efficacy trials

BACKGROUND: Genotyping of the three Plasmodium falciparum polymorphic genes, msp1, msp2 and glurp, has been adopted as a standard strategy to distinguish recrudescence from new infection in drug efficacy clinical trials. However, the suitability of a particular gene is compromised in areas where its...

Descripción completa

Detalles Bibliográficos
Autores principales: Atroosh, Wahib M., Lau, Yee-Ling, Snounou, Georges, Azzani, Meram, Al-Mekhlafi, Hesham M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725490/
https://www.ncbi.nlm.nih.gov/pubmed/34983529
http://dx.doi.org/10.1186/s12936-021-04014-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725490/
https://www.ncbi.nlm.nih.gov/pubmed/34983529
http://dx.doi.org/10.1186/s12936-021-04014-4

Ejemplares similares